India To Ease Clinical Trial Rules To Attract Global Pharma, Cut Red Tape, And Speed Up Drug Approvals

The Union Health Ministry has proposed key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019 to simplify licensing procedures and accelerate the pace of pharmaceutical research in India.